Neurodegenerative disease: Citalopram drives down amyloid-β
Nature Reviews Drug Discovery 13, 496 (2014).
doi:10.1038/nrd4378
Author: Charlotte Harrison
Serotonin signalling suppresses the production of amyloid-β (Aβ) in animal models of Alzheimer's disease. Sheline et al. showed that the antidepressant citalopram — a selective serotonin reuptake inhibitor — prevented the growth of pre-existing Aβ plaques and reduced the appearance of new plaques in
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Charlotte Harrison Tags: Research Highlight Source Type: research